Montelukast moderately decreased asthma symptoms in children with persistent asthma
- PMID: 11985443
- DOI: 10.7326/acpjc-2002-136-3-102
Montelukast moderately decreased asthma symptoms in children with persistent asthma
Comment on
-
Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.Pediatrics. 2001 Sep;108(3):E48. doi: 10.1542/peds.108.3.e48. Pediatrics. 2001. PMID: 11533366 Clinical Trial.